| About the author: |
Yu. D. Frenkel, V. S. Cherno, V. O. Zyuzin, V. V. Pshychenko, I. I. Starchenko, V. O. Kostenko, A. P. Stepanchuk |
| Heading |
EXPERIMENTAL MEDICINE |
| Type of article |
Scentific article |
| Annotation |
Using an experimental model, we studied the features of the state of the rat's liver tissues under the conditions of experimental metabolic syndrome with quercetin correction. Features of the state of tissues and their morphometric characteristics were microscopically determined in semi-thin histological sections. The majority of hepatocytes visually did not differ from those in the control group and were characterized by a polygonal shape with distinct contours. Hepatic cells with necrotic changes were not detected. Hepatocytes with signs of fatty dystrophy, in which osmiophilic inclusions were present in the cytoplasm, were periodically encountered. In general, sinusoidal capillaries contained some blood corpuscles, some moderately dilated. Although the cross-sectional area of hepatocytes decreased compared to the previous experimental group without correction, it remained larger compared to intact animals. The area of the cytoplasm of liver cells also decreased significantly. The cross-sectional area of the hepatocyte nucleus did not differ much from the previous experimental group. Accordingly, the nuclear-cytoplasmic ratio significantly increased in hepatocytes after quercetin correction, but was lower compared to intact animals. An increase in the number of mononuclear hepatocytes, which practically did not differ from the corresponding indicator in intact animals, should also be considered a morphological manifestation of the protective action of the polyphenol Quercetin in metabolic syndrome. |
| Tags |
metabolic syndrome,quercetin,liver,hepatocytes,nuclear-cytoplasmic ratio |
| Bibliography |
- Anokhina HA, Kharchenko VV, Dynnyk OB. Rol zapalennya ta metabolichnykh porushen u prohresuvanni khronichnykh zakhvoryuvan pechinky: profilaktyka ta likuvannya. Medychna hazeta «Zdorovya Ukrayiny 21 storichchya» [Internet]. 2018 Sep [cited 2022 Sep 19]; 15–16 (436–437):60–62 Dostupno: https://health-ua.com/multimedia/userfiles/files /2018/ZU_15-16_2018_st60-62.pdf. [in Ukrainian]
- Mustafina HM. Strukturni osoblyvosti hepatotsytiv bilykh shchuriv. Aktualni problemy suchasnoyi medytsyny. Visnyk Ukrayinskoyi medychnoyi stomatolohichnoyi akademiyi. 2021;2(74):146–150. doi:10.31718/2077-1096.21.2.146 [in Ukrainian]
- VII Natsionalnyi konhres z bioetyky. Natsionalna akademiya medychnykh nauk Ukrainy [onovleno 09 Zhov. 2019; cit. 01 Ber. 2021]. Dostupno: http://amnu.gov.ua/vii-naczionalnyj-kongres-z-bioetyky. [in Ukrainian]
- Frenkel YuD, Zyuzin VO, Cherno VS, Kostenko VO. Vplyv epihalokatekhykn-3-halatu ta kvertsetynu na utvorennya aktyvnykh form kysnyu ta azotu v pechintsi shchuriv za umov yikh tsilodobovoho osvitlennya ta utrymannya na vuhlevodno-lipidniy diyeti. Fiziol. zhurn. 2022; 68(1):20–27. [in Ukrainian]
- Chorna VV, Khlyestova SS, Humenyuk NI, Makhnyuk VM, Sydorchuk TM. Pokaznyky zakhvoryuvanosti i poshyrenosti ta suchasni pohlyady na profilaktyku khvorob. Visnyk Vinnytskoho natsionalnoho medychnoho universytetu. 2020; 24 (1):158–164. doi: 10.31393/reports-vnmedical-2020-24(1)-31. [in Ukrainian].
- Shepitko VI, Voloshyna OV, Pelypenko LB. Porivnyalna kharakterystyka morfolohiyi hepatotsytiv pry vplyvi riznykh patohennykh faktoriv. Visnyk problem biolohiyi i medytsyny. 2019; 2(149):55–59. doi: 10.29254/2077-4214-2019-1-2-149-55-59 [in Ukrainian]
- Cano-Martínez A, Bautista-Pérez R, Castrejón-Téllez V, Carreón-Torres E, Pérez-Torres I, Díaz-Díaz E, et al. Resveratrol and Quercetin as Regulators of Inflammatory and Purinergic Receptors to Attenuate Liver Damage Associated to Metabolic Syndrome. Int J Mol Sci. 2021 Aug 19;22(16):8939. doi: 10.3390/ijms22168939.
- Eslam M, Sanyal AJ, George J, International Consensus Panel. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158(7):1999–2014.e1. doi: 10.1053/j.gastro.2019.11.312.
- Frenkel YuD, Cherno VS, Kostenko VO. Nrf2 induction alleviates metabolic disorder and systemic inflammatory response in rats under a round-the-clock lighting and high-carbohydrate-lipid diet. Romanian Journal of Diabetes, Nutrition and Metabolic Diseases. 2022;29(2):194–201. doi: 10.31393/reports-vnmedical-2020-24(1)-31.
- Mykytenko AO, Akimov OYe, Yeroshenko GA, Neporada KS. Morphological and functional changes of the hepatic vascular bed under the conditions of modeling alcoholic hepatitis. World of medicine and biology. 2021. 3(77):229–236. doi: 10.26724/2079-8334-2021-3-77-229-236.
- Ostrowska OL, Bogdański P, Mamcarz A. Otyłość i jej powikłania: praktyczne zalecenia diagnostyczne i terapeutyczne. Wydawnictwo Lekarskie PZWL, Warszawa: 2021. [in Polish].
- Saklayen MG. The global epidemic of the metabolic syndrome. Curr. Hypertens. Rep. 2018 Feb 26;20(2):12. doi: 10.1007/s11906-018-0812-z.
- Swarup S, Goyal A, Grigorova Y, Zeltser R. Metabolic Syndrome. USA: Treasure Island (FL): StatPearls Publishing 2020.
- Targher G, Corey KE, Byrne CD, Roden M. The complex link between NAFLD and type 2 diabetes mellitus – mechanisms and treatments. Nat Rev Gastroenterol Hepatol. 2021 Sep;18(9):599–612. doi: 10.1038/s41575-021-00448-y.
- Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease. Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016 Jul;64(1):73–84. doi: 10.1002/hep.28431.
|
| Publication of the article |
«World of Medicine and Biology» №1(83), 2023 year, 243-247 pages, index UDK 616.36-091.8-008.9-092.4 |
| DOI |
10.26724/2079-8334-2023-1-83-243-247 |
